A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD3.98
- USD3.98
- USD3.86
- USD3.98
- 28.50%
- 18M
- 729.79k
- 938.40k
- 696M
- 1.69
- 84.00%
Stock News
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
yesterday
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Yahoo
yesterday
Search competition fears hit Alphabet stock yet again. We see no reason to join the sellers
CNBC
yesterday
ATI Physical Therapy to Announce Second Quarter 2024 Financial Results
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
